Sword Health is a company.
Sword Health has raised $327.0M across 6 funding rounds.
Key people at Sword Health.
Sword Health has raised $327.0M in total across 6 funding rounds.
Key people at Sword Health.
Sword Health has raised $327.0M in total across 6 funding rounds.
Sword Health's investors include General Catalyst, Giant Ventures, Khosla Ventures, Lakestar, Owl Capital, Reach Capital, Rethink Impact, Marc Benioff, Siqi Chen, Acrew Capital, AllegisCyber Capital, Alumni Ventures.
Sword Health is a digital health company building AI-powered physical therapy programs for musculoskeletal (MSK) conditions, pelvic health, injury prevention, and whole-person care. It serves employers, health plans, and individuals by delivering scalable, clinician-guided therapy via app-based exercises, wearables, and AI personalization, solving barriers like access, cost, and geography in traditional healthcare.[1][2][6] The platform combines human clinical specialists for empathy with AI for hyper-personalization, achieving outcomes like 67% of members reaching pain-free status, 70% pain reduction, and $3,177 average annual medical cost savings per engaged member.[6][7]
Founded in 2015, Sword has raised over $340 million, reached a $3 billion valuation by 2024, and expanded internationally with offices in the US, Ireland, and Portugal. Growth includes pilots in 2018, US office launch, awards in 2019, and products like Bloom (pelvic health, 2022) and Predict (surgery risk AI, 2023), backed by 40+ peer-reviewed papers.[1][2]
Sword Health was founded in 2015 in Portugal by Virgílio "V" Bento (CEO) and Márcio Colunas, driven by a mission to free the world from pain through equitable AI care.[1][2] Bento, with a background in engineering and healthcare innovation, identified gaps in MSK care—where pain affects billions but access is limited by location, cost, and disparities.[2][3]
The idea emerged from Bento's vision to blend AI with human clinicians, starting with a 2016 prototype using wearable motion sensors and AI therapy. Early traction came in 2017 via feasibility studies on AI rehab, 2018 pilots abroad, US expansion funding, and 2019 UCSF Digital Health Award for employer wellness.[1] Pivotal moments include 2022's Bloom launch for pelvic health and 2023's Predict tool plus clinical studies on engagement and surgery avoidance, fueling global scaling.[1]
Sword rides the digital health and AI care wave, targeting the $3.7 trillion global MSK market where chronic pain burdens 2 billion people amid clinician shortages and rising costs.[1][2] Timing aligns with post-pandemic telehealth acceleration, AI maturity for personalization, and employer demands for ROI-driven benefits—evidenced by partnerships with health plans and studies showing surgery/cost reductions.[1][6]
Market forces favor Sword: health equity mandates, diverse population needs, and "iron triangle" breakage (cost/quality/access) via AI scalability.[2][3] It influences the ecosystem by publishing outcomes research, setting standards for AI-clinician hybrids, and proving digital therapy's efficacy, inspiring competitors while expanding access for underserved groups.[1][4]
Sword's trajectory points to deepened AI integration, global expansion, and whole-person care evolution—potentially adding mental health or prevention suites amid aging populations and value-based care shifts.[2][6] Trends like clinician augmentation via AI, regulatory support for digital therapeutics, and employer wellness ROI will propel growth, with $3B valuation underscoring momentum.[1]
As Bento's pain-free mission scales, Sword could redefine MSK as preventive and equitable, influencing how tech humanizes healthcare for billions—starting from its Portuguese roots to worldwide impact.[1][2]
Sword Health has raised $327.0M across 6 funding rounds. Most recently, it raised $40.0M Venture Round in June 2025.
